Media enquiries
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.
Do you have
any question?
Saint Cloud, France – 4th July 2019
The Ethypharm Group is announcing that, via its subsidiary in Germany, it has entered into an
agreement with the Kalceks under which Ethypharm is obtaining exclusive distribution rights in
Germany for injectables with a base of Dexketoprofen, Oxycodone, Hydromorphone and Midazolam.
Thank you for your message!
We will examine it with utmost attention and get back to you shortly.